87 Inhibition of Autophagy: a Phase 1 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Analysis of Hydroxychloroquine in Combination with the HDAC Inhibitor, Vorinostat, in Patients with Advanced Solid Tumors
Devalingam Mahalingam(The University of Texas at San Antonio Health Science Center), Jennifer S. Carew(University of Arizona), Ravi K. Amaravadi(University of Pennsylvania), John Sarantopoulos(St. Boniface Hospital), Steffan T. Nawrocki(University of Arizona), Tyler J. Curiel(Tulane University), Alain C. Mita(Cedars-Sinai Medical Center), Lara E. Davis(Oregon Health & Science University), M. Mita(Samueli Institute)
Cited by 0
Related Papers
Guidelines for the use and interpretation of assays for monitoring autophagy
|Autophagy|2012|4.1k
Autophagy in major human diseases
|The EMBO Journal|2021|1.6k
Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma
|Journal of Clinical Investigation|2007|1.1k
Recent insights into the function of autophagy in cancer
|Genes & Development|2016|817
Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
|Clinical Cancer Research|2008|782